华法林药物基因组学试验：药物基因组学指导剂量是否有未来？
Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?
机构信息
Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1497, New York, NY 10029, USA.
出版信息
Pharmacogenomics. 2014 Apr;15(6):719-22. doi: 10.2217/pgs.14.18.
Abstract
“In clinical practice, it is common for warfarin to be initiated at a fixed dose for the first several doses.”
摘要
在临床实践中，华法林通常在前几次剂量中采用固定剂量起始。
相似文献
1
Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?
Pharmacogenomics. 2014 Apr;15(6):719-22. doi: 10.2217/pgs.14.18.
2
Meta-analysis of efficacy and safety of genotype-guided pharmacogenetic dosing of warfarin.
Int J Cardiol. 2014 Dec 15;177(2):654-7. doi: 10.1016/j.ijcard.2014.09.174. Epub 2014 Oct 7.
3
Pharmacogenomics of warfarin: uncovering a piece of the warfarin mystery.
Am J Health Syst Pharm. 2009 Jan 15;66(2):123-33. doi: 10.2146/ajhp080127.
4
Validation of pharmacogenetic algorithms and warfarin dosing table in Egyptian patients.
Int J Clin Pharm. 2012 Dec;34(6):837-44. doi: 10.1007/s11096-012-9678-3. Epub 2012 Jul 27.
5
Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation.
Circulation. 2007 Nov 27;116(22):2563-70. doi: 10.1161/CIRCULATIONAHA.107.737312. Epub 2007 Nov 7.
6
Outcomes of pharmacogenetics-guided dosing of warfarin: a systematic review and meta-analysis.
Int J Cardiol. 2014 Aug 20;175(3):587-91. doi: 10.1016/j.ijcard.2014.06.031. Epub 2014 Jun 28.
7
Warfarin pharmacogenomics in children.
Pediatr Blood Cancer. 2013 Sep;60(9):1402-7. doi: 10.1002/pbc.24592. Epub 2013 May 16.
8
Genotype-based dosing algorithms for warfarin therapy: data review and recommendations.
Mol Diagn Ther. 2011 Oct 1;15(5):255-64. doi: 10.1007/BF03256417.
9
A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).
Circulation. 2012 Apr 24;125(16):1997-2005. doi: 10.1161/CIRCULATIONAHA.111.070920. Epub 2012 Mar 19.
10
Genetic and clinical factors relating to warfarin dosing.
Trends Pharmacol Sci. 2009 Jul;30(7):375-86. doi: 10.1016/j.tips.2009.05.001. Epub 2009 Jun 17.
引用本文的文献
1
In Vivo Functional Effects of a Novel and Common Variant in the Yup'ik Alaska Native Population.
Drug Metab Dispos. 2021 May;49(5):345-352. doi: 10.1124/dmd.120.000301. Epub 2021 Feb 25.
2
Nonalcoholic fatty liver disease impacts the control of the international normalized ratio in patients with atrial fibrillation.
Ann Transl Med. 2020 Aug;8(16):1008. doi: 10.21037/atm-20-5387.
3
A path to precision in the ICU.
Crit Care. 2017 Apr 3;21(1):79. doi: 10.1186/s13054-017-1653-x.
4
STRATEGIES FOR EQUITABLE PHARMACOGENOMIC-GUIDED WARFARIN DOSING AMONG EUROPEAN AND AFRICAN AMERICAN INDIVIDUALS IN A CLINICAL POPULATION.
Pac Symp Biocomput. 2017;22:545-556. doi: 10.1142/9789813207813_0050.
5
Other side of the coin for personalised medicine and healthcare: content analysis of 'personalised' practices in the literature.
BMJ Open. 2016 Jul 13;6(7):e010243. doi: 10.1136/bmjopen-2015-010243.
6
Implementing Algorithm-Guided Warfarin Dosing in an Ethnically Diverse Patient Population Using Electronic Health Records and Preemptive CYP2C9 and VKORC1 Genetic Testing.
Clin Pharmacol Ther. 2016 Nov;100(5):427-430. doi: 10.1002/cpt.425. Epub 2016 Aug 18.
7
Contrasting Medical and Legal Standards of Evidence: A Precision Medicine Case Study.
J Law Med Ethics. 2016 Mar;44(1):194-204. doi: 10.1177/1073110516644210.
8
Revisiting Warfarin Dosing Using Machine Learning Techniques.
Comput Math Methods Med. 2015;2015:560108. doi: 10.1155/2015/560108. Epub 2015 Jun 4.
9
Closing the gap between knowledge and clinical application: challenges for genomic translation.
PLoS Genet. 2015 Feb 26;11(2):e1004978. doi: 10.1371/journal.pgen.1004978. eCollection 2015.
10
Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans.
Pharmacogenet Genomics. 2015 Feb;25(2):73-81. doi: 10.1097/FPC.0000000000000108.
本文引用的文献
1
A randomized trial of genotype-guided dosing of warfarin.
N Engl J Med. 2013 Dec 12;369(24):2294-303. doi: 10.1056/NEJMoa1311386. Epub 2013 Nov 19.
2
A pharmacogenetic versus a clinical algorithm for warfarin dosing.
N Engl J Med. 2013 Dec 12;369(24):2283-93. doi: 10.1056/NEJMoa1310669. Epub 2013 Nov 19.
3
Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans.
Pharmacogenomics J. 2014 Jun;14(3):223-8. doi: 10.1038/tpj.2013.34. Epub 2013 Sep 10.
4
A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).
Circulation. 2012 Apr 24;125(16):1997-2005. doi: 10.1161/CIRCULATIONAHA.111.070920. Epub 2012 Mar 19.
5
Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest. 2012 Feb;141(2 Suppl):7S-47S. doi: 10.1378/chest.1412S3.
6
Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy.
Blood. 2011 Sep 15;118(11):3163-71. doi: 10.1182/blood-2011-03-345173. Epub 2011 Jul 1.
7
Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design.
Pharmacogenomics J. 2012 Oct;12(5):417-24. doi: 10.1038/tpj.2011.18. Epub 2011 May 24.
8
Clinical trials for pharmacogenomics testing for warfarin dosing: relevance to general community practices.
Genet Med. 2011 Jun;13(6):505-8. doi: 10.1097/GIM.0b013e31821db51a.
9
A randomized controlled trial of genotype-based Coumadin initiation.
Genet Med. 2011 Jun;13(6):509-18. doi: 10.1097/GIM.0b013e31820ad77d.
10
Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study).
J Am Coll Cardiol. 2010 Jun 22;55(25):2804-12. doi: 10.1016/j.jacc.2010.03.009. Epub 2010 Apr 8.
Zotero 插件